Literature DB >> 31140425

[Expression of NUF2 in breast cancer and its clinical significance].

Jingbo Sun1, Jiawei Chen2, Zhizhi Wang2, Yunyao Deng1, Lixin Liu1, Xiaolong Liu1.   

Abstract

OBJECTIVE: To investigate the expression of the cell division- associated gene NUF2 in breast cancer and its clinical significance.
METHODS: The expression of NUF2 in breast cancer tissues was analyzed using Oncomine database. The relationship between the expression of NUF2 and the prognosis of breast cancer was analyzed using the Kaplan-Meier Plotter database. Gene set enrichment analysis (GSEA) and GEO database were used to investigate the effect of NUF2 on gene enrichment. The String database was utilized to analyze the proteins associated with NUF2. The TIMER database was analyzed to assess the correlations of NUF2 with BUB1, MAD2L1 and MYC. The expressions of NUF2 mRNA in 8 pairs of breast cancer tissues and adjacent tissues were verified by q-PCR.
RESULTS: Compared with that in normal breast tissue, NUF2 was significantly overexpressed in breast cancer (P < 0.001). The overall survival time (HR = 1.52, P = 0.015) and the recurrence-free survival time (HR = 1.85, P = 3.2e-14) of the patients with high NUF2 expression were significantly shorter than those of patients with low NUF2 expression. In patients with high NUF2 expression, the enriched genes were involved mainly in cell cycle, P53, G2/M, DNA repair, MYC, and PI3K-AKT-MTOR signaling pathways, which were associated with tumor proliferation, invasion, metastasis and stemness. Combination of the results of String database, gene enrichment and TIMER database analyses suggested that NUF2 interacted directly with BUB1, MAD2L1, and MYC, which could promote the progression of breast cancer. The results of q-PCR showed that NUF2 expression was up-regulated in 6 cancer tissues and down-regulated in 2 cancer tissues.
CONCLUSIONS: NUF2 gene is overexpressed in breast cancer, and its expression level is important in predicting the prognosis of breast cancer.

Entities:  

Keywords:  NUF2; breast cancer; database analysis; prognosis

Mesh:

Substances:

Year:  2019        PMID: 31140425      PMCID: PMC6743945          DOI: 10.12122/j.issn.1673-4254.2019.05.15

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  24 in total

1.  Nuf2 is required for chromosome segregation during mouse oocyte meiotic maturation.

Authors:  Teng Zhang; Yang Zhou; Shu-Tao Qi; Zhen-Bo Wang; Wei-Ping Qian; Ying-Chun Ouyang; Wei Shen; Heide Schatten; Qing-Yuan Sun
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  p53 mediated transcriptional regulation of long non-coding RNA by 1-hydroxy-1-norresistomycin triggers intrinsic apoptosis in adenocarcinoma lung cancer.

Authors:  Vaikundamoorthy Ramalingam; Krishnamoorthy Varunkumar; Vilwanathan Ravikumar; Rajendran Rajaram
Journal:  Chem Biol Interact       Date:  2018-03-27       Impact factor: 5.192

3.  Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer.

Authors:  Mahnaz Janghorban; Amy S Farrell; Brittany L Allen-Petersen; Carl Pelz; Colin J Daniel; Jessica Oddo; Ellen M Langer; Dale J Christensen; Rosalie C Sears
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-09       Impact factor: 11.205

Review 4.  Tumor dormancy and MYC inactivation: pushing cancer to the brink of normalcy.

Authors:  Catherine M Shachaf; Dean W Felsher
Journal:  Cancer Res       Date:  2005-06-01       Impact factor: 12.701

5.  Silencing of NUF2 inhibits tumor growth and induces apoptosis in human hepatocellular carcinomas.

Authors:  Qiang Liu; She-Jiao Dai; Hong Li; Lei Dong; Yu-Ping Peng
Journal:  Asian Pac J Cancer Prev       Date:  2014

6.  p53 target miR-29c-3p suppresses colon cancer cell invasion and migration through inhibition of PHLDB2.

Authors:  Geng Chen; Tong Zhou; Yang Li; Zhenxiang Yu; Liankun Sun
Journal:  Biochem Biophys Res Commun       Date:  2017-04-07       Impact factor: 3.575

7.  SiRNA-mediated knockdown against NUF2 suppresses tumor growth and induces cell apoptosis in human glioma cells.

Authors:  S-K Huang; J-X Qian; B-Q Yuan; Y-Y Lin; Z-X Ye; S-S Huang
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2014-11-25       Impact factor: 1.770

8.  Phase I clinical trial of cell division associated 1 (CDCA1) peptide vaccination for castration resistant prostate cancer.

Authors:  Wataru Obara; Fuminori Sato; Kazuyoshi Takeda; Renpei Kato; Yoichiro Kato; Mitsugu Kanehira; Ryo Takata; Hiromitsu Mimata; Tamotsu Sugai; Yusuke Nakamura; Tomoaki Fujioka
Journal:  Cancer Sci       Date:  2017-06-23       Impact factor: 6.716

9.  Identification of the potential crucial genes in invasive ductal carcinoma using bioinformatics analysis.

Authors:  Chunguang Li; Liangtao Luo; Sheng Wei; Xiongbiao Wang
Journal:  Oncotarget       Date:  2017-12-13

Review 10.  Tumour suppressor mechanisms in the control of chromosome stability: insights from BRCA2.

Authors:  Ashok R Venkitaraman
Journal:  Mol Cells       Date:  2014-02-19       Impact factor: 5.034

View more
  1 in total

1.  Expression and clinical significance of NUF2 in kidney renal clear cell carcinoma.

Authors:  Li Shan; Xiao-Li Zhu; Yuan Zhang; Guo-Jian Gu; Xu Cheng
Journal:  Transl Androl Urol       Date:  2021-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.